AIA makes major play in health insurance market

The new Real Health product introduces new $500,000 limits on surgical and non-surgical treatments, including new generation, non-Pharmac treatments for cancer, such as the innovative immunotherapy treatments, that are otherwise unaffordable for the average New Zealander.

AIA chief executive Natalie Cameron says: “Our new Real Health policy directly addresses the affordability issues for these new treatments, but we’re also moving to address the general affordability of insurance cover for the average New Zealander by introducing a generous discount regime on premiums.”

AIA customers who purchase the Real Life policy together with other insurance policies receive an escalating discount per extra policy.

“The more policies that are bundled up, the greater the discount that is available,” Cameron says.